- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy - Abstract
November 14, 2011
Renal tumors associated with germline SDHB mutation show distinctive morphology - Abstract
November 11, 2011
Predictors of locally advanced and metastatic disease in patients with small renal masses - Abstract
November 10, 2011
Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: A propensity scoring approach - Abstract
November 10, 2011
Critical appraisal of pazopanib as treatment for patients with advanced metastatic renal cell carcinoma - Abstract
November 9, 2011
Sunitinib, hypertension, and heart failure: A model for kinase inhibitor-mediated cardiotoxicity - Abstract
November 9, 2011
Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma - Abstract
November 7, 2011
Radiofrequency ablation of renal tumors: Our experience - Abstract
November 4, 2011
Obesity is an adverse factor on laparoscopic radical nephrectomy for t2 but not t1 renal cell carcinoma - Abstract
November 4, 2011
Better late than early: FDG-PET imaging in metastatic renal cell carcinoma - Abstract
November 3, 2011
Validation of the 2009 TNM classification for renal cell carcinoma: Comparison with the 2002 TNM classification by Concordance Index - Abstract
November 3, 2011
Impact of cisplatin administration on protein expression levels in renal cell carcinoma: A proteomic analysis - Abstract
November 2, 2011
Role of immunotherapy for renal cell cancer in 2011 - Abstract
November 1, 2011